COCHLEAR FPO (ASX: COH) Share Price and News
Chart and Price Data
20mins delayed
| Price | |
| Bid/Ask | / |
| Volume | |
| Avg Daily Volume |
| Day Movement | |
| Day High/Low | / |
| 52 Week Range | - |
| Year Return (Capital) | |
| As at |
Cochlear Limited (COH) is a global leader in implantable hearing devices. The company manufactures and distributes cochlear implantable devices for hearing impaired.
Based in Sydney, Cochlear has operations in more than 20 countries, distributing its products in America, Asia Pacific, Europe, the Middle East and Africa. It offers three main products: Cochlear implants, Baha bone conduction implants and Cochlear Wireless Accessories.
Cochlear was formed in 1981, with COH shares first listing on the ASX almost 15 years later in 1995. Since then, the Cochlear share price has risen exponentially and the company is now one of the largest-listed companies on the ASX.
COCHLEAR FPO (ASX: COH) Latest News
Is the Cochlear share price the one that got away?
Kenneth Hall | November 20, 2019 9:46am
The Cochlear Ltd (ASX: COH) share price has been rocketing higher for a number of years, but you may not have missed out on... More »
Where I would invest $10,000 in ASX 200 shares today
James Mickleboro | November 19, 2019 2:48pm
Altium Limited (ASX:ALU) shares are one of three that I would invest $10,000 into this week. Here's why I think they could be market... More »
Is Sonic Healthcare the best dividend share on the ASX?
Tom Richardson | November 19, 2019 11:59am
Sonic shares are up more than 10x since 1999 and you cannot beat the combination of rising dividends and share prices as an investor. More »
Cochlear share price higher on FDA approval news
James Mickleboro | November 18, 2019 10:26am
The Cochlear Limited (ASX:COH) share price is pushing higher on Monday after receiving FDA approval for the Osia 2 System. More »
Will the Nanosonics share price surge higher in 2020?
Kenneth Hall | October 31, 2019 1:06pm
The Nanosonics Ltd (ASX: NAN) share price has been a top performer on the ASX 200 this year - but will the momentum continue... More »
Why I think Apple shares still look a great bet
Tom Richardson | October 31, 2019 12:34pm
Apple shares have an awful lot going for them including the company's finanical strength and market-leading product offering. More »
3 quality blue chip ASX shares to buy in November
James Mickleboro | October 28, 2019 3:20pm
SEEK Limited (ASX:SEK) shares are one of three blue chip ASX shares that I think investors should buy in November... More »
ResMed shares higher after earnings beat
Tom Richardson | October 25, 2019 9:12am
ResMed is quickly becoming one of Australia's biggest listed companies. What's behind its phenomenal success? More »
Top brokers name 3 ASX shares to sell today
James Mickleboro | October 24, 2019 2:50pm
Cochlear Limited (ASX:COH) shares are one of three that top brokers have rated as sells... More »
5 things to watch on the ASX 200 on Wednesday
James Mickleboro | October 23, 2019 7:10am
Cochlear Limited (ASX:COH), Costa Group Holdings Ltd (ASX:CGC), and WiseTech Global Ltd (ASX:WTC) shares will be on watch on the ASX 200 today... More »
ALL ORDINARIES finishes higher Tuesday: 8 ASX shares you missed
Tristan Harrison | October 22, 2019 4:31pm
The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) finished higher on Tuesday, here are 8 ASX shares you missed. More »
Why Cann, Cochlear, Megaport, & Super Retail shares tumbled lower today
James Mickleboro | October 22, 2019 1:50pm
The Cochlear Limited (ASX:COH) share price and the Super Retail Group Ltd ASX:SUL) share price are two of four tumbling lower on Tuesday... More »
ASX 200 lunch update: NAB higher, Cochlear and Super Retail lower
James Mickleboro | October 22, 2019 12:08pm
Cochlear Limited (ASX: COH), National Australia Bank Ltd (ASX:NAB), and Super Retail Group Ltd ASX:SUL) shares are making waves on the ASX 200 index on... More »
Has Cochlear got its “head in the sand” over potential $380 million legal bill?
Tom Richardson | October 22, 2019 11:58am
The Alfred Mann Foundation is now demanding up to US$391 million from Cochlear. More »